Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04056910 | Ivosidenib (AG-120) With Nivolumab in IDH1 Mutant Tumors | completed | Phase 2 | 15 | Jason J. Luke, MDOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT05997589 | Financial Health Educational Program for Increasing Financial Literacy Among Underserved Communities in Western New York | completed | N/A | 99 | Roswell Park Cancer InstituteOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT01251562 |
| Safety Study of Sterile Compound C31510 for Injection to Subjects With Solid Tumors |
| completed |
| Phase 1 |
| 50 |
| BPGbioINDUSTRY |
| 1 |
| Feb 19, 2025 |
| clinicaltrials |
| NCT01957735 | BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors | completed | Phase 1 | 97 | BPGbioINDUSTRY | 1 | Feb 19, 2025 | clinicaltrials |
| NCT03956680 | An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers | completed | Phase 1 | 54 | Bristol-Myers SquibbINDUSTRY | 2 | Feb 19, 2025 | clinicaltrials |
| NCT04537715 | Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels | completed | Phase 1 | 42 | Epizyme, Inc.INDUSTRY | 2 | Feb 19, 2025 | clinicaltrials |
| NCT05188664 | Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 20 | LaNova Australia Pty LimitedINDUSTRY | 1 | Feb 17, 2025 | clinicaltrials |
| NCT03654716 | Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer | completed | Phase 1 | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT05943041 | Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer | completed | Phase 1 | 9 | GILongevityINDUSTRY | 1 | Feb 14, 2025 | clinicaltrials |
| NCT02070549 | Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction | completed | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 2 | Feb 13, 2025 | clinicaltrials |
| NCT04666688 | LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 / Phase 2 | 44 | PureTechINDUSTRY | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04805307 | Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 | completed | Phase 1 | 176 | Keymed Biosciences Co.LtdINDUSTRY | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06172894 | PBMC-based Leukocyte Immunotherapy(PALINDROM) | completed | Phase 1 | 10 | invIOs GmbHINDUSTRY | 1 | Feb 12, 2025 | clinicaltrials |
| NCT02188264 | Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 2 | Feb 11, 2025 | clinicaltrials |
| NCT05178888 | Adagrasib in Combination With Palbociclib in Patients With Advanced Solid Tumors (KRYSTAL-16) | completed | Phase 1 | 11 | Mirati Therapeutics Inc.INDUSTRY | 1 | Feb 11, 2025 | clinicaltrials |
| NCT01586104 | Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases | completed | N/A | 20 | Ann & Robert H Lurie Children's Hospital of ChicagoOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT02503709 | Onalespib and CDKI AT7519 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 29 | National Cancer Institute (NCI)NIH | 1 | Feb 10, 2025 | clinicaltrials |
| NCT02631733 | Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Feb 10, 2025 | clinicaltrials |
| NCT02667873 | A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors | completed | Phase 1 | 72 | Stemline Therapeutics, Inc.INDUSTRY | 1 | Feb 10, 2025 | clinicaltrials |
| NCT01638533 | Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 2 | Feb 7, 2025 | clinicaltrials |
| NCT03213691 | Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 2 | Feb 5, 2025 | clinicaltrials |
| NCT02876510 | ACTolog in Patients With Solid Cancers(ACTolog) | completed | Phase 1 | 38 | Immatics US, Inc.INDUSTRY | 1 | Feb 4, 2025 | clinicaltrials |
| NCT03247309 | TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101)(ACTengine) | completed | Phase 1 | 7 | Immatics US, Inc.INDUSTRY | 2 | Feb 4, 2025 | clinicaltrials |
| NCT03441100 | TCR-engineered T Cells in Solid Tumors: IMA202-101(ACTengine) | completed | Phase 1 | 16 | Immatics US, Inc.INDUSTRY | 2 | Feb 4, 2025 | clinicaltrials |
| NCT03628677 | A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies | completed | Phase 1 | 75 | Arcus Biosciences, Inc.INDUSTRY | 2 | Feb 4, 2025 | clinicaltrials |
| NCT03760952 | Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling | completed | — | 242 | Immatics US, Inc.INDUSTRY | 1 | Feb 4, 2025 | clinicaltrials |
| NCT04574583 | Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT) | completed | Phase 1 / Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Feb 3, 2025 | clinicaltrials |
| NCT03447470 | Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies | completed | Phase 1 | 46 | Redx Pharma LtdINDUSTRY | 1 | Jan 29, 2025 | clinicaltrials |
| NCT02116530 | Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy | completed | Phase 3 | 401 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT05908773 | A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors | completed | Early Phase 1 | 1 | TransCode TherapeuticsINDUSTRY | 1 | Jan 28, 2025 | clinicaltrials |
| NCT06112002 | Evaluation of an Education Program to Increase Knowledge and Participation in Clinical Trials Among Racial/Ethnic and Rural Populations | completed | N/A | 78 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT06258330 | Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors | completed | Phase 1 | 12 | Aummune Ltd.INDUSTRY | 1 | Jan 28, 2025 | clinicaltrials |
| NCT03220035 | Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) | completed | Phase 2 | 4 | National Cancer Institute (NCI)NIH | 2 | Jan 27, 2025 | clinicaltrials |
| NCT05775406 | Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors | completed | Phase 1 | 52 | Kymera Therapeutics, Inc.INDUSTRY | 1 | Jan 27, 2025 | clinicaltrials |
| NCT01946789 | A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors | completed | Phase 1 | 26 | Altor BioScienceINDUSTRY | 1 | Jan 22, 2025 | clinicaltrials |
| NCT02240238 | Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer | completed | Phase 1 / Phase 2 | 119 | NanoCarrier Co., Ltd.INDUSTRY | 5 | Jan 22, 2025 | clinicaltrials |
| NCT05613036 | A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body | completed | Phase 1 | 13 | Boehringer IngelheimINDUSTRY | 1 | Jan 22, 2025 | clinicaltrials |
| NCT03518606 | Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours(MOVIE) | completed | Phase 1 / Phase 2 | 126 | UNICANCEROTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT03982082 | Ultrasound in Evaluating Muscle-Glycogen Content in Cancer Patients | completed | N/A | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT04622774 | First-in-Human Study of IMGC936 in Participants With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 56 | ImmunoGen, Inc.INDUSTRY | 3 | Jan 15, 2025 | clinicaltrials |
| NCT01902173 | Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer | completed | Phase 1 / Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2025 | clinicaltrials |
| NCT02323880 | Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas | completed | Phase 1 | 59 | Children's Oncology GroupNETWORK | 1 | Jan 14, 2025 | clinicaltrials |
| NCT02975882 | Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 33 | Children's Oncology GroupNETWORK | 1 | Jan 14, 2025 | clinicaltrials |
| NCT05346692 | Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer | completed | Early Phase 1 | 73 | Emory UniversityOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT05766332 | Evaluating Clinical Evaluation Tools for Predicting Risk of Complications After Hematopoietic Stem Cell Transplant | completed | — | 137 | Mayo ClinicOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT04539574 | An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors | completed | N/A | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT06012708 | Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713 | completed | Phase 1 | 12 | New Cancer Cure-Bio Co.,Ltd.INDUSTRY | 1 | Jan 8, 2025 | clinicaltrials |
| NCT04727554 | Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors | completed | Phase 1 | 11 | AmgenINDUSTRY | 10 | Jan 6, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Feb 27, 2025source: clinicaltrials